pamidronate has been researched along with Acute Disease in 17 studies
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine whether pamidronate is a safe and effective agent for the treatment of severe hypercalcemia of malignancy in children." | 7.70 | Use of pamidronate in the management of acute cancer-related hypercalcemia in children. ( Shende, A; Young, G, 1998) |
| "To review the use of pamidronate to treat immobilization hypercalcemia after acute spinal cord injury (SCI) in 9 cases." | 7.70 | Immobilization hypercalcemia treatment with pamidronate disodium after spinal cord injury. ( Cardenas, DD; Massagli, TL, 1999) |
| "We performed a randomized, double-blind, controlled clinical trial comparing intravenous pamidronate and placebo for pain relief in recent osteoporotic vertebral compression fractures (VCF)." | 5.12 | Intravenous pamidronate for pain relief in recent osteoporotic vertebral compression fracture: a randomized double-blind controlled study. ( Armingeat, T; Brondino, R; Lafforgue, P; Legré, V; Pham, T, 2006) |
| "To determine whether pamidronate is a safe and effective agent for the treatment of severe hypercalcemia of malignancy in children." | 3.70 | Use of pamidronate in the management of acute cancer-related hypercalcemia in children. ( Shende, A; Young, G, 1998) |
| "To review the use of pamidronate to treat immobilization hypercalcemia after acute spinal cord injury (SCI) in 9 cases." | 3.70 | Immobilization hypercalcemia treatment with pamidronate disodium after spinal cord injury. ( Cardenas, DD; Massagli, TL, 1999) |
| "As hypercalcemia is a serious metabolic complication, a gradual dose reduction should be considered when interruption of high dose denosumab therapy is planned." | 2.61 | Acute hypercalcemia and excessive bone resorption following anti-RANKL withdrawal: Case report and brief literature review. ( Brazeau-Lamontagne, L; Dufresne, J; Huot Daneault, A; Massicotte, MH; Roux, S, 2019) |
| "Mild anterior uveitis is an unfamiliar adverse effect of pamidronate therapy." | 1.34 | Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost. ( Palimar, P; Quah, S; Ramasamy, B; Sahni, JN, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Bostrom, B | 1 |
| Akhtar, J | 1 |
| Gorantla, VK | 1 |
| Snell, PD | 1 |
| Wall, BM | 1 |
| Roux, S | 1 |
| Massicotte, MH | 1 |
| Huot Daneault, A | 1 |
| Brazeau-Lamontagne, L | 1 |
| Dufresne, J | 1 |
| Auron, A | 1 |
| Tal, L | 1 |
| Srivastava, T | 1 |
| Alon, US | 1 |
| Haibel, H | 1 |
| Brandt, J | 1 |
| Rudwaleit, M | 1 |
| Soerensen, H | 1 |
| Sieper, J | 1 |
| Braun, J | 1 |
| Klein, GL | 1 |
| Wimalawansa, SJ | 1 |
| Kulkarni, G | 1 |
| Sherrard, DJ | 1 |
| Sanford, AP | 1 |
| Herndon, DN | 1 |
| Armingeat, T | 1 |
| Brondino, R | 1 |
| Pham, T | 1 |
| Legré, V | 1 |
| Lafforgue, P | 1 |
| Ramasamy, B | 1 |
| Quah, S | 1 |
| Sahni, JN | 1 |
| Palimar, P | 1 |
| Wendling, D | 1 |
| Tisserand, G | 1 |
| Griffond, V | 1 |
| Saccomani, C | 1 |
| Toussirot, E | 1 |
| Landman, JO | 1 |
| Schweitzer, DH | 1 |
| Frölich, M | 1 |
| Hamdy, NA | 1 |
| Papapoulos, SE | 1 |
| Reading, PJ | 1 |
| Newman, PK | 1 |
| Kelly, WF | 1 |
| Bateson, MC | 1 |
| Rothwell, P | 1 |
| Young, G | 1 |
| Shende, A | 1 |
| Devogelaer, JP | 1 |
| Nagant de Deuxchaisnes, C | 1 |
| Nance, PW | 1 |
| Schryvers, O | 1 |
| Leslie, W | 1 |
| Ludwig, S | 1 |
| Krahn, J | 1 |
| Uebelhart, D | 1 |
| Massagli, TL | 1 |
| Cardenas, DD | 1 |
| Abdulla, AJ | 1 |
| Canivet, JL | 1 |
| Damas, P | 1 |
| Lamy, M | 1 |
1 review available for pamidronate and Acute Disease
| Article | Year |
|---|---|
Acute hypercalcemia and excessive bone resorption following anti-RANKL withdrawal: Case report and brief literature review.
Topics: Acute Disease; Bone and Bones; Bone Resorption; Female; Humans; Hypercalcemia; Middle Aged; Pamidron | 2019 |
4 trials available for pamidronate and Acute Disease
| Article | Year |
|---|---|
The efficacy of acute administration of pamidronate on the conservation of bone mass following severe burn injury in children: a double-blind, randomized, controlled study.
Topics: Absorptiometry, Photon; Acute Disease; Adolescent; Amino Acids; Anti-Inflammatory Agents; Biomarkers | 2005 |
Intravenous pamidronate for pain relief in recent osteoporotic vertebral compression fracture: a randomized double-blind controlled study.
Topics: Acute Disease; Aged; Aged, 80 and over; Analgesics; Back Pain; Bone Density Conservation Agents; Dip | 2006 |
Recovery of serum calcium concentrations following acute hypocalcemia in patients with osteoporosis on long-term oral therapy with the bisphosphonate pamidronate.
Topics: Acute Disease; Administration, Oral; Aged; Calcium; Diphosphonates; Edetic Acid; Female; Humans; Hyp | 1995 |
Intravenous pamidronate attenuates bone density loss after acute spinal cord injury.
Topics: Acute Disease; Bone and Bones; Bone Density; Bone Resorption; Collagen; Collagen Type I; Diphosphona | 1999 |
12 other studies available for pamidronate and Acute Disease
| Article | Year |
|---|---|
Comment on: "Team approach: Management of osteonecrosis in children with acute lymphoblastic leukemia: An ounce of prevention is worth a pound of cure: Consideration of prophylactic pamidronate.
Topics: Acute Disease; Child; Humans; Osteonecrosis; Pamidronate; Precursor Cell Lymphoblastic Leukemia-Lymp | 2021 |
Acute esophageal necrosis (black esophagus) complicating calcific uremic arteriolopathy
.
Topics: Acute Disease; Aged; Arterioles; Bone Density Conservation Agents; Esophagitis; Esophagoscopy; Esoph | 2019 |
Reversal of hypercalcemic acute kidney injury by treatment with intravenous bisphosphonates.
Topics: Acute Disease; Adolescent; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates | 2009 |
Treatment of active ankylosing spondylitis with pamidronate.
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Diphosphonates; Female; Follow-Up Studies; Hum | 2003 |
Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost.
Topics: Acute Disease; Administration, Topical; Aged, 80 and over; Anti-Inflammatory Agents; Bone Density Co | 2007 |
Acute pseudogout after pamidronate infusion.
Topics: Acute Disease; Aged; Chondrocalcinosis; Diphosphonates; Humans; Infusions, Intravenous; Male; Pamidr | 2008 |
Treatment of immobilisation hypercalcaemia in acute intermittent porphyria: experience from three cases.
Topics: Acute Disease; Adolescent; Adult; Diphosphonates; Female; Humans; Hypercalcemia; Pamidronate; Porphy | 1997 |
Use of pamidronate in the management of acute cancer-related hypercalcemia in children.
Topics: Acute Disease; Adolescent; Calcium; Child; Child, Preschool; Diphosphonates; Female; Humans; Hyperca | 1998 |
Use of pamidronate in chronic and acute bone loss conditions.
Topics: Acute Disease; Bone Density; Bone Resorption; Chronic Disease; Diphosphonates; Female; Humans; Male; | 1997 |
Immobilization hypercalcemia treatment with pamidronate disodium after spinal cord injury.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Calcium; Diphosphonates; Dose-Response R | 1999 |
Use of pamidronate for acute pain relief following osteoporotic vertebral fractures.
Topics: Acute Disease; Aged; Aged, 80 and over; Analgesics; Diphosphonates; Female; Humans; Middle Aged; Ost | 2000 |
Posttraumatic parathyroid crisis and severe hypercalcemia treated with intravenous bisphosphonate (APD). Case report.
Topics: Abdominal Injuries; Acute Disease; Brain Concussion; Diphosphonates; Female; Humans; Hypercalcemia; | 1990 |